Navigation Links
Boehringer Ingelheim to Purchase Amgen's Fremont (USA) Facility
Date:1/31/2011

SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ -- Global Real Estate Consultants has helped Boehringer Ingelheim to strengthen their global presence with a new facility in Fremont.

Global Real Estate Consultants was retained by Boehringer Ingelheim to provide insight and transparency in the Fremont commercial real estate market specifically related to their purchase of Amgen Inc's 350,000 sq. ft. state-of-the-art manufacturing facility with pilot plant and process development labs. "We looked for an international tenant representation specialist to help us undertake a real estate acquisition in a new geographical area. We chose Global Real Estate Consultants because we felt that their level of expertise would best represent our interest," states Dr. Maier-Erbacher of Boehringer Ingelheim.

"We provided Boehringer Ingelheim with unrivaled objective information and transparency," says founder and company principal Erich Struzyk. "At the end we were able to provide savings for our client which they initially did not expect. Boehringer Ingelheim especially appreciated the fact that we do not represent landlords and thus avoided the typical conflicts of interest inherent in the brokerage market."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. For over 125 years, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development (http://www.boehringer-ingelheim.com).

About Global Real Estate Consult
'/>"/>

SOURCE Global Real Estate Consultants
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
2. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
3. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
4. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
5. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
6. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
7. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
8. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
9. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
10. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
11. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  BiOptix is pleased to ... as Vice President of Chemistry and Biochemistry. Scott joins the ... AstraZeneca Pharmaceuticals, and Amgen throughout the course of his ... "Scott is a nationally recognized thought leader ...
(Date:1/22/2015)...  ResMed Inc. (NYSE: RMD ) today announced results ... quarter was $423.0 million, a 10 percent increase compared to ... on a constant currency basis). Net income was $91.2 million, ... December 31, 2013. Diluted earnings per share for the quarter ...
(Date:1/22/2015)... Jan. 22, 2015  Amgen (NASDAQ: AMGN ) today announced ... financial results on Tuesday, Jan. 27, 2015, after the close of ... conference call with the investment community at 2 p.m. PT. Participating ... , chairman and chief executive officer, and other members of Amgen,s ...
Breaking Medicine Technology:BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
... (OTCPK: SNDY) is pleased to announce that the Company ... and sales of its high quality instruments for the ... 2011, Solos Endoscopy consummated agreements, which resulted in the ... The signed settlement agreement and new consulting agreement resulted ...
... Inc. (Nasdaq: MSHL ), an oncology company ... cancer metabolism, announced today that it has reached a ... sell common stock in a private placement for gross ... of the offering, through the sale of approximately 1.94 ...
Cached Medicine Technology:Solos Endoscopy, Inc. is Primed for Growth in 2012 2Solos Endoscopy, Inc. is Primed for Growth in 2012 3Marshall Edwards Adds $2 Million in Private Placement 2Marshall Edwards Adds $2 Million in Private Placement 3
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together ... by up to 30lbs in less than 12 weeks without ... Stevenson, prompting an investigative review. , “Our Incredible Bulk ... formula that allows the body to pack on a massive ...
(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... effective ways to control weight , , FRIDAY, Dec. 26 (HealthDay ... suppressing appetite, according to a U.K. study. , The ... types of sessions. In one, they ran for 60 minutes ... another, they did 90 minutes of weight lifting and then ...
... Most women expressed satisfaction with process, but long-term data lacking, ... who choose to donate eggs to help infertile couples should ... the first study to examine the long-term effects of donation ... is available to assess whether donating eggs when young has ...
... to date and avoid local dangers, expert advises , , ... sunnier climes this winter, kids in tow? , If ... advises an expert. , "The most common infectious ... of the world may result from exposure to contaminated ...
... basic safety rules should help keep celebrants safe , , ... the holidays, tens of thousands of Americans have to ... injuries and illnesses. That includes about 11,000 people with ... president of the American College of Emergency Physicians. ...
... practice and center for sound sleep in the Midwest is warning ... to a energy-robbing and dangerous disease known as sleep apnea. ... while sleeping. , ... Bloomington, Ind. (PRWEB) December 25, ...
... in children and adolescents should be recognized and treated ... disorders and depression, says a nationally recognized child psychiatrist ... appearing in the Dec. 25 issue of New ... of psychiatry and pediatrics at UT Southwestern, urges awareness ...
Cached Medicine News:Health News:Vigorous Treadmill Workout Curbs Appetite Hormones 2Health News:Risks and Benefits of Egg Donation Reported 2Health News:Risks and Benefits of Egg Donation Reported 3Health News:Consider Kids' Health on Tropical Trips 2Health News:How to Avoid a Holiday Trip to the ER 2Health News:Holiday Weight Gain May Contribute to Sleep Apnea Extra Pounds May Produce Severe Problems for Adults 2Health News:Childhood anxiety disorders can and should be treated, according to UT Southwestern national expert 2
1.5 mm inner cutting edge....
Phaco chopper & iris retractor 2 mm cutting edge....
Round handle dull finish. For right handed surgeon....
Cross action, round handle, maximum opening 2.8 mm....
Medicine Products: